Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/27/2025

Evaluation of Hepatitis

Biochemical Tests

  • The American Association for the Study of Liver Diseases recommends that the liver profile in suspected hepatitis should include transaminases (ALT/AST), bilirubin, alkaline phosphatase, GGT, prothrombin time, albumin, and platelet count, in addition to specific serological markers according to the suspected type of hepatitis 1, 2
  • Elevated alkaline phosphatase and GGT suggest a cholestatic pattern, important for differentiating between types of hepatitis 2
  • Prothrombin time/INR reflects the liver's synthetic capacity and is an important prognostic indicator 1
  • Serum albumin is a marker of long-term liver function 1, 3
  • Platelet count may decrease in advanced liver disease with portal hypertension 1, 3

Serological Markers

  • For hepatitis B, a complete panel including HBsAg, anti-HBs, anti-HBc IgM, anti-HBc IgG, HBeAg, and anti-HBe is recommended to evaluate viral replication and infectivity 1, 4, 5, 6
  • Hepatitis C diagnosis involves anti-HCV antibodies and confirmation with HCV RNA qualitative/quantitative testing 7
  • Hepatitis D diagnosis involves anti-HDV and HDV RNA (only in HBsAg-positive patients) 8

Interpretation of Results

  • A hepatocellular pattern is characterized by predominant elevation of transaminases (ALT/AST) over alkaline phosphatase 2
  • A cholestatic pattern is characterized by predominant elevation of alkaline phosphatase and GGT over transaminases 2
  • The magnitude of transaminase elevation does not always correlate with the histological severity of the disease 7
  • Normal transaminase levels do not rule out significant liver disease, especially in chronic hepatitis C and B 7
  • The presence of thrombocytopenia, hypoalbuminemia, and prolonged prothrombin time suggests advanced liver disease 1, 3

Additional Evaluation

  • Abdominal ultrasound is recommended in all patients with abnormal liver tests to evaluate liver structure, rule out focal lesions, and signs of portal hypertension 1, 2
  • Liver elastography is a non-invasive assessment of fibrosis 1, 8
  • Liver biopsy is considered when biochemical and viral marker results are inconclusive or to assess the degree of activity and fibrosis 1, 7